STOFFEL, S. T.; VON MOOS, R.; THÜRLIMANN, B.; CATHOMAS, R.; GILLESSEN, S.; ZÜRRER-HÄRDI, U.; VON BRIEL, T.; ANCHISI, S.; FELLER, A.; SCHÄR, C.; DIETRICH, D.; SCHWENKGLENKS, M.; LUPATSCH, J. E.; MARK, M. Patterns of care and economic consequences of using bone-targeted agents for castration-sensitive prostate cancer patients with bone metastases to prevent skeletal-related events in Switzerland – the SAKK 95/16 prostate study. Swiss Medical Weekly, [S. l.], v. 151, n. 0910, p. w20464, 2021. DOI: 10.4414/smw.2021.20464. Disponível em: https://smw.ch/index.php/smw/article/view/2968. Acesso em: 17 jun. 2024.